Unknown

Dataset Information

Proton pump inhibitors induce changes in the gut microbiome composition of systemic lupus erythematosus patients.


ABSTRACT:

Background

Currently, few studies focus on the association between gut microbiota and systemic lupus erythematosus (SLE), and much less studies consider the effect of drug usage. Proton pump inhibitors (PPIs) are commonly used to treat drug-related gastrointestinal damage in SLE patients. Therefore, the purpose of this study is to examine the gut microbiota of SLE patients using PPIs.

Methods

Fecal samples from 20 SLE patients with PPIs (P-SLE), 20 SLE patients without PPIs (NP-SLE) and 17 healthy controls (HCs) were obtained. The structure of the bacterial community in the fecal samples was analyzed by 16S rRNA gene sequencing. Redundancy analysis (RDA) was performed to observe the relationship between clinical variables and microbiome composition in P-SLE and NP-SLE patien

SUBMITTER: Li XB 

PROVIDER: S-EPMC9043501 | biostudies-literature | 2022 Apr

REPOSITORIES: biostudies-literature